Concepedia

Hany Rofael

HR

9

Publications

381

Citations

9

H-Index

2002

Active since

Affiliations

Janssen (United States)(Current)

Rutgers, The State University of New Jersey

Rutgers New Jersey Medical School

Brigham and Women's Hospital

University of Southern California

Hany Rofael is an author at Janssen (United States) specializing in medicine, pharmacology, and health sciences.

Top concepts

Publications per year

2002–2024

9

Publications

9

Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease

Reisa A. Sperling, David Henley, Paul Aisen et al. · JAMA Neurology · 2021 · 101 citations · Full text

Development and validation of a high‐performance liquid chromatography method for the determination of cocaine, its metabolites and ketamine

Hany Rofael, Mohamed S. Abdel‐Rahman · Journal of Applied Toxicology · 2002 · 56 citations

, , +17

Randomized Trial of Macitentan/Tadalafil Single-Tablet Combination Therapy for Pulmonary Arterial Hypertension

Ekkehard Grünig, Pavel Jansa, Fenling Fan et al. · Journal of the American College of Cardiology · 2024 · 54 citations

A randomized Phase 2 study to evaluate the orexin-2 receptor antagonist seltorexant in individuals with insomnia without psychiatric comorbidity

Peter de Boer, Wayne C. Drevets, Hany Rofael et al. · Journal of Psychopharmacology · 2018 · 51 citations

Sensitivity of the Preclinical Alzheimer's Cognitive Composite (PACC), PACC5, and Repeatable Battery for Neuropsychological Status (RBANS) to Amyloid Status in Preclinical Alzheimer's Disease -Atabecestat Phase 2b/3 EARLY Clinical Trial

Kathryn V. Papp, Hany Rofael, Amy E. Veroff et al. · The Journal of Prevention of Alzheimer s Disease · 2022 · 30 citations · Full text

Rows per page

1–5 of 9